Search
Castle Biosciences Inc
CSTLAdd to Watchlist
34.800USD
-0.080-0.23%
Market hours 09/24, 15:25（ET）
1.06BMarket Cap
LossP/E TTM
Castle Biosciences Inc (CSTL) Revenue Performance
Updated: Jun 30, 2026For the latest quarter, Castle Biosciences Inc reported the revenue of 152.25M USD for the period ending 2026-06-30, which came from the top-performing segment, Dermatologic. United States contributed the highest revenue, at 103.55M USD.
By Region
Revenue
Proportion
Annual
Annual
Quarterly
United States
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
United States
344.23M(100.00%)
332.07M(100.00%)
219.79M(100.00%)
--(--)
--(--)
--(--)
--(--)